Open AccessIn vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab
Author(s) -
S. Caratelli,
R. Arriga,
T. Sconocchia,
A. Ottaviani,
G. Lanzilli,
D. Pastore,
C. Cenciarelli,
A. Venditti,
Maria Ilaria Del Principe,
D. Lauro,
E. Landoni,
H. Du,
B. Savoldo,
S. Ferrone,
G. Dotti,
G. Sconocchia
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/e2bf-0b23
Subject(s) - cetuximab , panitumumab , epidermal growth factor receptor , in vitro , cancer research , chemistry , receptor , cancer , biology , medicine , colorectal cancer , biochemistry